End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,620 KRW | -3.24% | -8.13% | -38.39% |
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 55% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-38.39% | 352M | - | ||
+75.69% | 12.57B | B- | ||
-24.68% | 7.34B | C+ | ||
+12.58% | 5.39B | D+ | ||
-15.96% | 4.84B | B | ||
+26.90% | 4.53B | - | ||
-22.63% | 3.91B | B- | ||
-22.99% | 2.91B | C | ||
+47.42% | 2.37B | C- | ||
-0.12% | 2B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A099190 Stock
- Ratings i-SENS, Inc.